Does Hürthle cell carcinoma of the thyroid have a poorer prognosis than ordinary follicular thyroid carcinoma?

Annals of Surgical Oncology

Volumn 20, Issue 9, 2013, Pages 2944-2950

  Sugino, Kiminori ^a   Kameyama, Kaori ^b   Ito, Koichi ^a   Nagahama, Mitsuji ^a   Kitagawa, Wataru ^a   Shibuya, Hiroshi ^a   Ohkuwa, Keiko ^a   Uruno, Takashi ^a   Akaishi, Junko ^a   Suzuki, Akifumi ^a   Masaki, Chie ^a   Ito, Kunihiko ^a  

^a ITO HOSPITAL   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HURTHLE CELL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; ORDINARY FOLLICULAR THYROID CARCINOMA; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SUBTOTAL THYROIDECTOMY; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID SURGERY; THYROIDECTOMY; TUMOR INVASION; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 84881479343     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2965-y     Document Type: Article

References (32)

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C. WHO classification of tumours, pathology and genetics of tumours of endocrine organs. Lyon: IARC; 2004:73-6.
2. Bishop JA, Wu G, Tufano RP, Westra WH. Histological patterns of locoregional recurrence in Hürthle cell carcinoma of the thyroid gland. Thyroid. 2012;22:690-4.
3. DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab. 1995;80:2946-53.
4. Azadian A, Rosen I, Walfish P, Asa SL. Management considerations in Hurthle cell carcinoma. Surgery. 1995;118:711-4.
5. McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J. Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery. 1996;120:1000-4.
6. Shaha A, Loree T, Shah J. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery. 1995;118:1131-6.
7. Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hürthle cell tumors of the thyroid gland. Cancer. 1991;68:1944-53.
8. Harness JK, Thompson NW, McLeod MK, Eckhauser FE, Lloyd RV. Follicular carcinoma of the thyroid gland: trend and treatment. Surgery. 1984;96:972-80.
9. Kushchayeva Y, Duh QY, Kebebew E, Clark OH. Prognostic indications for Hürthle cell cancer. World J Surg. 2004;28:1266-70.
10. Kushchayeva Y, Duh QY, Kebebew E, D'Avanzo A, Clark OH. Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. Am J Surg. 2008;195:457-62.
11. Yutan E, Clark OH. Hürthle cell carcinoma. Curr Treat Options Oncol. 2001;2:331-5.
12. Evans HL, Vassilopoulou-Sellin R. Follicular and Hurthle cell carcinoma of the thyroid: a comparative study. Am J Surg Pathol. 1998;22:1512-20.
13. Sanders LE, Silverman M. Follicular and Hurthle cell carcinoma: predicting outcome and directing therapy. Surgery. 1998;124:967-74.
14. Khafif A, Khafif R, Attie J. Hurthle cell carcinoma: a malignancy of low-grade potential. Head Neck. 1999;21:506-11.
15. Grant CS, Hay ID, Ryan JJ, Bergstralh EJ, Rainwater LM, Goellner JR. Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World J Surg. 1990;14:283-9.
16. Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol. 1986;10:246-55.
17. Haigh PI, Urbach DR. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Surgery. 2005;138:1152-7.
18. Besic N, Auersperg M, Golouh R. Prognostic factors in follicular carcinoma of the thyroid-a multivariate survival analysis. Eur J Surg Oncol. 1999;25:599-605.
19. Ito Y, Hirokawa M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, et al. Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg. 2007;31:1417-24.
20. Sugino K, Ito K, Mimura T, Kameyama K, Iwasaki H, Ito K. Hürthle cell tumor of the thyroid: analysis of 188 cases. World J Surg. 2001;25:1160-3.
21. Mete O, Asa SL. Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules. Endocr Pathol. 2010;21:16-24.
22. Mills SC, Haq M, Smellie WJ, Harmer C. Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol. 2009;35:230-4.
23. Feldt-Rasmussen U. Iodine and cancer. Thyroid. 2001;11:483-6.
24. Bakiri F, Djemli FK, Mokrane LA, Djidel FK. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer. 1998;82:1146-53.
25. Paunovic I, Krgovic K, Tatic S, Diklic A, Zivaljevic V, Kalezic N, et al. Surgery for thyroid Hürthle cell tumours - a single institution experience. Eur J Surg Oncol. 2006;32:458-61.
26. Chen H, Nicol TL, Zeiger MA, Dooley WC, Ladenson PW, Cooper DS, et al. Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg. 1998;227:542-6.
27. Wasvary H, Czako P, Poulik J, Lucas R. Unilateral lobectomy for Hurthle cell adenoma. Am Surg. 1998;64:729-32.
28. Stojadinovic A, Hoos A, Ghossein RA, Urist MJ, Leung DH, Spiro RH, et al. Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol. 2002;9:197-203.
29. Bhattacharyya N. Survival and prognosis in Hürthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg. 2003;129:207-10.
30. Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordoñez NG, et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer. 2003;97:1186-94.
31. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, et al. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid. 2012;22:798-804.
32. Sugino K, Ito K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, et al. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Thyroid. 2011;21:751-7.